en · de · es · fr · pt
aod-9604-notes.peptides3626.com › Data › Research And Regulatory Context — Explained

Research And Regulatory Context — Explained

By Editorial Desk · published 2026-02-19 · last reviewed 2026-03-07 · Data

A practical reference on AOD9604: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2026-03-07 and is reviewed periodically as new material appears.

Research and Regulatory Context

Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.

Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.

Handling And Analytical Properties

Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.

AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.

Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.

Aod-9604 at a glance

PropertyValueNotes
Regulatory statusNot approved as a medicineMajor agencies have not authorized it for therapeutic use.
Anti-doping statusProhibited in sportListed among peptide hormones and related substances.
Primary research areaMetabolic and body-composition effectsStudies often examine fat mass or lipid markers.
Human evidenceLimited and mixedPublic data do not establish clinical efficacy.
Analytical detectionLC-MS and immunoassaysMethods vary in sensitivity and validation.

Background and Development History

Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.

AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.

Related pages on this site

Background and Molecular Identity

The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.

Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.

AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.

Further detail

=== Pharmacokinetics === Exposure to radioactive waste may cause health impacts due to ionizing radiation exposure. In humans, a dose of 1 sievert carries a 5.5% risk of developing cancer, and regulatory agencies assume the risk is linearly proportional to dose even for low doses. Ionizing radiation can cause deletions in chromosomes. If a developing organism such as a fetus is irradiated, it is possible a birth defect may be induced, but it is unlikely this defect will be in a gamete or a gamete-forming cell. The incidence of radiation-induced mutations in humans is small, as in most mammals, because of natural cellular-repair mechanisms, many just now coming to light. These mechanisms range from DNA, mRNA and protein repair, to internal lysosomic digestion of defective proteins, and even induced cell suicide—apoptosis Depending on the decay mode and the pharmacokinetics of an element (how the body processes it and how quickly), the threat due to exposure to a given activity of a radioisotope will differ. For instance, iodine-131 is a short-lived beta and gamma emitter, but because it concentrates in the thyroid gland, it is more able to cause injury than caesium-137 which, being water soluble, is rapidly excreted through urine. In a similar way, the alpha emitting actinides and radium are considered very harmful as they tend to have long biological half-lives and their radiation has a high relative biological effectiveness, making it far more damaging to tissues per amount of energy deposited.

== Function == Following binding of GnRH, the GnRHR associates with G-proteins that activate a phosphatidylinositol (PtdIns)-calcium second messenger system. Activation of the GnRHR ultimately causes the release of follicle stimulating hormone (FSH) and luteinizing hormone (LH).

Recruitment: This branch carries out Direct Recruitment (out of the 3 possible mechanisms of: 'direct recruitment', 'recruitment by promotion' and 'recruitment by transfer and permanent absorption') by selection to all Group `A’ and certain Group `B’ posts of the services of the Union (including some Union Territories). These recruitments are done either by selection (interview) or through competitive examination. Recruitment Rules: The commission is mandated under Art. 320 of the Constitution of India, read along the UPSC (Exemption from Consultation) Regulations, 1958, to advise on framing and amending of Recruitment and Service Rules for various Group A and Group B posts in the Government of India, and certain autonomous organizations like EPFO, ESIC, DJB, NDMC & Municipal Corporations(s) of Delhi. This Branch carries out this responsibility by facilitating the Ministries / Departments / UT Administrations / Autonomous Organisations in this regard. Services I: Handles disciplinary cases received from various Ministries/Departments and State Governments for the advice of the commission, as required under Article 320 (3)(c). Services II: Handles all other cases that the 'Services I' branch doesn't. It compiles the Annual Report. Also, it coordinates visits of foreign delegations, correspondence with foreign countries, and hosting of international events concerning Public Service Commissions, including the SAARC Member States.

Cytochrome P-450 is not a single enzyme, but rather consists of a closely related family of 50 isoforms; six of them metabolize 90% of drugs. There is a tremendous diversity of individual P-450 gene products, and this heterogeneity allows the liver to perform oxidation on a vast array of chemicals (including most drugs) in phase 1. Three important characteristics of the P-450 system have roles in drug-induced toxicity:

=== Mandatory breaks === Cooling or hydration breaks were introduced at the 2014 World Cup in Brazil. For the 2026 World Cup, FIFA introduced mandatory three-minute hydration breaks in every half for all matches. Broadcasters were permitted to run commercials during these pauses. Since the clock did not stop during the breaks, the three minutes were automatically included in the stoppage time for each half.

Sources: en.wikipedia.org

Background from the literature

== S == sarcoplasmic reticulum - satellite DNA - scientific notation - SDS-PAGE - second messenger - second messenger system - secondary structure - secretin - selectin - sensory receptor - sequence (biology) - sequence homology - sequence motif - sequencing - serine - serotonin - serotonin receptor - serpin - sexual reproduction - SH3 domain - SI - sigma factor - signal peptide - signal recognition particle - signal sequence - signal transduction - sincalide - skeleton - skin - smooth ER - sodium channel - sodium-hydrogen antiporter - soluble - solution - solvation - solvent - somatomedin - somatomedin receptor - somatostatin - somatostatin receptor - somatotropin - somatotropin receptor - somatotropin-releasing hormone - somatropin - sp1 transcription factor - spectrin - spectroscopy - src gene - src-family kinase - SSRI - starch - stem cell - stereochemistry - steroid 17alpha-monooxygenase - steroid 21-monooxygenase - steroid receptor - stimulatory gs G-protein - stoichiometry - structural biology - structural domain - Structural formula - structural motif - substance P - substrate - sugar - sulfur - supercoil - superfamily - superoxide - surface immunoglobulin - surface plasmon resonance - suspension (chemistry) - synapse - synthetic vaccine - systems biology

Risk of addiction and abuse Potentially fatal respiratory depression Lethal overdose in accidental ingestion QT prolongation Neonatal opioid withdrawal syndrome in children of pregnant women CYP450 drug interactions Risks when used with alcohol, benzodiazepines, and other CNS depressants. A certified opioid treatment program is required under federal law (42 CFR 8.12) when dispensing methadone for the treatment of opioid addiction.

=== Animal feed === Food allergies also occur in cats and in dogs. When the allergy is due to a protein in the food, the issue can be avoided by hydrolyzing the proteins into smaller components. Hydrolyzed protein is therefore used in specially formulated hypoallergenic pet foods. Partially hydrolyzed protein may also increase the development of immune tolerance. The increased protein digestibility is also potentially useful for pets with digestive issues such as inflammatory bowel disease, being in recovery from acute enteritis, and exocrine pancreatic insufficiency. Hydrolysing a usually indigestible protein can provide an additional source of digestible protein. An example of this is hydrolyzed feather meal, made from keratin-rich waste features from the poultry industry. With partial hydrolysis, it becomes a cheap, low-carbon source of protein that is digestible by ordinary livestock and pets. Although it retains the poor amino acid profile from feather, the good digestibility and high protein content makes it a good companion to other protein sources.

== Demographics == For the 2024–25 academic year, PGCPS boasts an enrollment of over 132,000 students. In the DC area, only neighboring Montgomery County Public Schools in Maryland and Fairfax County Public Schools in Virginia surpass this number. Based on September 2024 demographic data, the racial and ethnic composition of PGCPS students is as follows:

In August 2012, Domino's Pizza changed its name to simply Domino's. At the same time, Domino's introduced a new logo that removed the blue rectangle and text under the domino in the logo, and changed the formerly all-red domino to be blue on the side with two dots and red on the side with one dot. This was done because the company wanted to "expand" menu choices rather than simply rely on its traditional pizza. In April 2022, Domino's Italy franchise operator EPizza SpA filed for bankruptcy at a Milan court after two years of declining sales caused by the COVID-19 lockdowns in Italy. In addition, Domino's Pizza faced competition from local pizza chains and restaurants, which had begun using food delivery app services such as Glovo, Just Eat and Deliveroo. The reason for the failure, however, is mainly that the customer rating of Domino's outlets is very low in Italy, which explains the difficulty of competing with the high quality of Italian pizzas. After the 90-day grace period expired in July 2022, Domino's closed all its Italian stores on 20 July. In 2023, following the Russian invasion of Ukraine, Domino's Russian operations also filed for bankruptcy and Domino's ultimately announced their withdrawal from the country, closing down all of their restaurants shortly after the announcement. On December 12, 2024, Domino's announced that it would transfer its stock to the Nasdaq Global Select Market which took effect on January 2, 2025 at the stock market open. The company retained the ticker symbol "DPZ".

Sources: en.wikipedia.org

Frequently asked questions

Is AOD-9604 approved for medical use?

No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.

Why is AOD-9604 banned in sports?

It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.

What do human studies show?

Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.

How should AOD-9604 be stored?

Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.

Network